Barclays PLC增持昭衍新药(06127)约327.98万股 每股作价约24.25港元

智通财经APP获悉，香港联交所最新资料显示，7月15日，Barclays PLC增持昭衍新药(06127)327.982万股，每股作价24.2508港元，总金额约为7953.83万港元。增持后最新持股数目约为728.53万股，最新持股比例为6.12%。

补充资料：Notifiable interest first occurred due to increase in Equity shares. BBPLCs interests in 2068664 shares long and short and BCSLs interests in 1295444 shares long and 773220 shares short as disclosed at box 22 pertain to an intragroup hedge between BBPLC and BCSL. Interests arising under the hedge are not double counted at BPLCs level.